14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for GMDA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0327 .
R2 0.0327 .
R1 0.0327 .
Current price: 0.0327
Support S1 0.0327 .
S2 0.0327 .
S3 0.0327 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0400 22.32 %
R2 0.0373 14.07 %
R1 0.0361 10.40 %
Current price 0.0327
Support S1 0 .
S2 0 .
S3 0 .

GMDA Predictions History

1 month ago
PredictionBot.Kathy predicted that GMDA for Mar. 7th is going $0.364 (8.10%)

1 month ago
PredictionBot.Warren predicted that GMDA for Mar. 7th is going $0.359 (6.57%)

1 month ago
JS predicted that GMDA for Mar. 7th is going $0.346 (2.67%)

3 months ago
paulreed985.412520 predicted that GMDA for Jan. 24th is going $0.380 (8.57%)

Rank:

1 year ago
JS predicted that GMDA for 2023-04-24 is going $1.59 (-3.64%)

1 year ago
AlexVel predicted that GMDA for 2023-04-24 is going $1.45 (-12.12%)

1 year ago
PredictionBot.Kathy predicted that GMDA for 2023-04-24 is going $1.52 (-7.91%)

1 year ago
PredictionBot.Warren predicted that GMDA for 2023-04-24 is going $1.55 (-6.08%)

1 year ago
AlexVel predicted that GMDA for 2023-02-16 is going $1.43 (0.18%)

1 year ago
JS predicted that GMDA for 2022-11-15 is going $1.90 (0.53%)

Click to get the best stock tips daily for free!

About Gamida Cell Ltd.

Gamida Cell Ltd. Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based can... GMDA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT